Creative Details

Quality Score: 5/10

The advertisement promotes Unicycive Therapeutics' investigational treatment for chronic kidney disease, highlighting its potential to improve medication adherence for patients on dialysis by addressing key shortcomings of existing therapies.

Creative Information

CID:1610026f-5be8-4c28-bf15-9a4842ceab15
CRID:25_kwj1frxz
Domain:unicycive.com
Seat:TTD
Size:300x250
Bid:$0.13
Timestamp:11/26/2025, 6:37:12 PM
Declared IAB Categories:

    Analysis

    5 succeeded1 failed(83% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess12/18/2025, 8:11:49 PM5.22s
    adomain_analysissuccess12/18/2025, 8:12:24 PM3.40s
    adomain_capturesuccess12/18/2025, 8:12:20 PM0.12s
    ad_rendersuccess12/18/2025, 8:11:44 PM28.83s
    brand_mappingsuccess12/18/2025, 8:09:51 PM0.11s
    video_analysisfailed12/18/2025, 8:11:44 PM0.09s

    Analysis Results

    Ad Format: banner

    Brands: unknown

    Quality:Adomain not match landing page domain
    Size:300x250
    Data Transferred:697.85 KB
    Render Time:8.28 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Creative Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Domain Inferred IAB Categories:
    • Uncategorized (IAB24)
    Landing Page:
    Total Ad Size:717.06 KB
    Requests Made:
    URLSize (KB)
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js227.08
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N1408331.3327153SPACEBACK/B31213279.431420046;dc_ver=106.314;dc_eid=40004000;sz=300x250;u_sd=1;nel=1;dc_adk=2027040026;ord=s0qamj;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3De9ab3387-efa7-4a72-97e6-713de64ef308%26ag%3Dxn96yt0%26sfe%3D1b5df642%26sig%3DVsf0fPtslhSjDDMsmhSl39CcmqCijJA_b0L3_YUc9Tw.%26crid%3Dkwj1frxz%26cf%3D9546926%26fq%3D0%26t%3D1%26td_s%3Dwww.mut.gg%26rcats%3D2ic%2C7gr%2Chhr%2Chmy%2C26o%2Czm4%2Cc6q%26mste%3D%26mfld%3D3%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D70%26agsa%3D%26wp%3D0.48113075%26rgz%3D20149%26dt%3DMobile%26osf%3DiOS%26os%3DiOS186%26br%3DSafari%26svpid%3D8482%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DMobileOptimizedWeb%26tmpc%3D7.8700000000000045%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMFQSdFwBDZINROUG4XFtUbk1Uji0qx4XLDUsNMBgxiELAVkAfWCTGEhwMGRpB4PNVRMxV91ZEDL0r_2lW64jPC6sqKTeFDhFpJIYSFqsFVjqQqNxSQFl5e1YQNdoggEKbDepJI5Xb7HG9jBlzAbHNnTJ5w8TlHrw-wdCYZ752KXbXw1-8jZM-2AZiw7RL3afzkrnO5v3I3GHl3xfrcT2jVP0atBarf7PWJu0vohK_Tp_WWClP7a4wurr_iPnX8fpk1r4c26wGe2VcyewY12zKi3Vxt7_zKtQGwaSy7ghvm7BQrp3TJJiSKo1qvYBC2ozMabaFd0kkGM-_YyH06LvG-y5btI_6UXsPjT327ovafak9My5xL19POzXrec-bDAhG1Wsj2dfYsausx8a0Ef8Kcrm-n9J6duZFdlRupVx1lJrFnok1hdasmZILNQMGq2BhZ7-kz8Yiw5rFHEgtOpHA5BLf-XzEKGxFaAqXLiu2iBijDWU51d_jH77rP6Zh3bZ1M777uh-H69n-c10c_7_OjuXaz-1Za4-NFIoK4VjD04SRmBmOiJggAKdoyp6tEufEhmOTq8n-ad1x6MgkSFqsGMhz3su4P9MxXOv--Y91Oe7XdjK5ZaUgpwmmNK6W-sfMNHukeDXQsaaIELZubatKR0Qjpoh8vFzUSEwWPZld2PxN67oez_fetmOtDgV0ykryz19PVgM-_MHsaMndUoC1M1zxED7yG8XzdOCTaTcKF3dPSGXofi-dJepec3ADSVMUVKpMK-flO1UxHyJ_v8z7wY1_JNCA9DmlvmobzuKCaVamwNvTLbAL35Pj05xB3mGQStEeRKcR1uNZHJoCcQY7OJ0PKobp_N9_0er5X07dn_tkULctRJMzQ6agl2JoACX-d9hC2prYk344-EREEDKoZh9Vub8KWqW_Ygsr0TMbY49jprwzrAazJDvtHA_HpKA_hLXMW_JSsow7KyM60dSzWUTPneZdltajz-fw--gua_X2DH1inVDzIg..%26dur%3D1~KLUv_WMFoCgkcAIFCQCjjCsXoGEoEp8ILiCD67S4Wg73lxnSznY4I8dQ60oj5pslVTGksSHpGMw_GSk5ZdCbmgQwyRlvARzt5k1ChMcEiceE88GHx6QJEZ4TOIwAo8JzEsUEGIE8GjGekxyWKAKH1ySSR8PIo0ni0Zzxw6sZ4jkp4jmh4m2cKoY0tnh05GSUpDNNRgRN5-5P3PnmHYaXUw3plRT2vT_0fX5e-2S1ThDk2TrexuGpJOskX5mmRQsj_Dx2AT962arT_IOimrZCdJ5czKSCDs6428-tiNdR246cElS55jKIzxoVkMiAtIsY2zekN3dfpzqjZsBiel1jEiSPpWhCgk1IY6DzjaxCxaAM33KVpxmNLyoxEGr8cBHn47YIKdJ0dqKOfbCEFxA.%26durs%3D72HdI6%26bdc%3D131%26uidd%3DoKDDA8igFQlLrF9LkTQv6DgEZTSsGFYnzhYwtHkUZvwro5JC%26idl%3DXY3007pyhNWPZZthEDzzGR8M41vdXONVRWM5arSFW7mBdYqxQ%26mk%3DApple%26mdl%3DiPhone%26testid%3D%2520TTDContextualTest%2520iavc1%2520%26fpa%3D792%26pcm%3D3%26ict%3DEthernet%26said%3D369e5216-f501-4f11-9516-44f5898d6355%26auct%3D1%26us_privacy%3D1YNY%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=hWj.J8PQ2q;stc=1;chaa=1;sttr=45;prcl=s92.15
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/cEKNWemrxTs4NW8H3E33JwLPZapylAUFwGQa1dnzZcE.js53.32
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=tradedesk01&aid=tradedesk01&cid=a8hyl2b_xn96yt0_kwj1frxz&c=tradedesk01cont1&js=pmw0&w=300&h=250&sid=0&dsarequired=&dsabehalf=&dsapaid=&dsaparams=21.19
    https://choices.trustarc.com/get?name=pmw2.js19.05
    https://www.googletagservices.com/dcm/dcmads.js16.68
    https://s0.2mdn.net/sadbundle/16423071998673416786/05ae6048-967c-4423-8674-b23f47fe5fcd.jpg11.79

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1